Prostatic Artery Embolization in Patients with Prostate Cancer: A Systematic Review
European Urology Focus · 2024-05 · 10 (3) · 387-399
DOI: 10.1016/j.euf.2023.02.005 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Urology Focus, 2024-05. Verfasst von Orlando Burkhardt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland. Electronic address: o.burkhardt@burkhardt-home.ch. Hauptthemen laut MEDLINE: Embolization, Therapeutic, Prostatic Neoplasms, Prostate. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland. Electronic address: o.burkhardt@burkhardt-home.ch.
- Department of Urology, Spitalzentrum Biel/Centre Hospitalier Bienne, Biel/Bienne, Switzerland.
- Department of Urology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland.
- Department of Urology, Spital Thun, Thun, Switzerland.
Zitieren
APA
Burkhardt, O., Abt, D., Engeler, D., Schmid, H. P., Müllhaupt, G., & Zumstein, V. (2024). Prostatic Artery Embolization in Patients with Prostate Cancer: A Systematic Review. European Urology Focus, 10(3), 387-399. https://doi.org/10.1016/j.euf.2023.02.005
Vancouver
Burkhardt O, Abt D, Engeler D, Schmid HP, Müllhaupt G, Zumstein V. Prostatic Artery Embolization in Patients with Prostate Cancer: A Systematic Review. European Urology Focus. 2024;10(3):387-399. doi:10.1016/j.euf.2023.02.005
BibTeX
@article{Burkhardt2024,
author = {Burkhardt, Orlando and Abt, Dominik and Engeler, Daniel and Schmid, Hans-Peter and Müllhaupt, Gautier and Zumstein, Valentin},
title = {Prostatic Artery Embolization in Patients with Prostate Cancer: A Systematic Review},
journal = {European Urology Focus},
year = {2024},
volume = {10},
number = {3},
pages = {387--399},
doi = {10.1016/j.euf.2023.02.005}
}
EUVIMED